|
1
|
Gupta GP and Massagué J: Cancer
metastasis: building a framework. Cell. 127:679–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fanali C, Lucchetti D, Farina M, et al:
Cancer stem cells in colorectal cancer from pathogenesis to
therapy: controversies and perspectives. World J Gastroenterol.
20:923–42. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen K, Huang YH and Chen JL:
Understanding and targeting cancer stem cells: therapeutic
implications and challenges. Acta Pharmacol Sin. 34:732–740. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Clevers H: The cancer stem cell: premises,
promises and challenges. Nat Med. 17:313–319. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xie K, Huang S, Dong Z, Gutman M and
Fidler IJ: Direct correlation between expression of endogenous
inducible nitric oxide synthase and regression of M5076 reticulum
cell sarcoma hepatic metastases in mice treated with liposomes
containing lipopeptide CGP 31362. Cancer Res. 55:3123–3131.
1995.PubMed/NCBI
|
|
7
|
Wong CW, Lee A, Shientag L, et al:
Apoptosis: an early event in metastatic inefficiency. Cancer Res.
61:333–338. 2001.PubMed/NCBI
|
|
8
|
Oliver L, Cordel S, Barbieux I, et al:
Resistance to apoptosis is increased during metastatic
dissemination of colon cancer. Clin Exp Metastasis. 19:175–180.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ljunggren HG and Malmberg KJ: Prospects
for the use of NK cells in immunotherapy of human cancer. Nat Rev
Immunol. 7:329–339. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Malmberg KJ, Bryceson YT, Carlsten M, et
al: NK cell-mediated targeting of human cancer and possibilities
for new means of immunotherapy. Cancer Immunol Immunother.
57:1541–1552. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Smyth MJ, Cretney E, Kelly JM, et al:
Activation of NK cell cytotoxicity. Mol Immunol. 42:501–510. 2005.
View Article : Google Scholar
|
|
12
|
Micheau O, Shirley S and Dufour F: Death
receptors as targets in cancer. Br J Pharmacol. 169:1723–1744.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Long EO, Kim HS, Liu D, Peterson ME and
Rajagopalan S: Controlling natural killer cell responses:
integration of signals for activation and inhibition. Annu Rev
Immunol. 31:227–258. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chan CJ, Smyth MJ and Martinet L:
Molecular mechanisms of natural killer cell activation in response
to cellular stress. Cell Death Differ. 21:5–14. 2014. View Article : Google Scholar
|
|
15
|
Morikawa K, Walker SM, Nakajima M, Pathak
S, Jessup JM and Fidler IJ: Influence of organ environment on the
growth, selection, and metastasis of human colon carcinoma cells in
nude mice. Cancer Res. 48:6863–6871. 1988.PubMed/NCBI
|
|
16
|
Elkins K, Zheng B, Go M, et al: FcRL5 as a
target of antibody-drug conjugates for the treatment of multiple
myeloma. Mol Cancer Ther. 11:2222–2232. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hennel R, Brix N, Seidl K, et al: Release
of monocyte migration signals by breast cancer cell lines after
ablative and fractionated γ-irradiation. Radiat Oncol. 9:852014.
View Article : Google Scholar
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
Jaenisch R and Young R: Stem cells, the
molecular circuitry of pluripotency and nuclear reprogramming.
Cell. 132:567–582. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hamburger AW and Salmon SE: Primary
bioassay of human tumor stem cells. Science. 197:461–463. 1977.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Um JH, Kwon JK, Kang CD, et al:
Relationship between antiapoptotic molecules and metastatic potency
and the involvement of DNA-dependent protein kinase in the
chemosensitization of metastatic human cancer cells by epidermal
growth factor receptor blockade. J Pharmacol Exp Ther.
311:1062–1070. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Alison MR, Lim SM and Nicholson LJ: Cancer
stem cells: problems for therapy? J Pathol. 223:147–161. 2011.
View Article : Google Scholar
|
|
23
|
Camps J, Morales C, Prat E, et al: Genetic
evolution in colon cancer KM12 cells and metastatic derivates. Int
J Cancer. 110:869–874. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
De Lange R, Burtscher H, Jarsch M and
Weidle UH: Identification of metastasis-associated genes by
transcriptional profiling of metastatic versus non-metastatic colon
cancer cell lines. Anticancer Res. 21:2329–2339. 2001.PubMed/NCBI
|
|
25
|
Saigusa S, Tanaka K, Toiyama Y, et al:
Correlation of CD133, OCT4, and SOX2 in rectal cancer and their
association with distant recurrence after chemoradiotherapy. Ann
Surg Oncol. 16:3488–3498. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
O’Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110. 2007.
View Article : Google Scholar
|
|
27
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
et al: Identification and expansion of human
colon-cancer-initiating cells. Nature. 445:111–115. 2007.
View Article : Google Scholar
|
|
28
|
Elsaba TM, Martinez-Pomares L, Robins AR,
et al: The stem cell marker CD133 associates with enhanced colony
formation and cell motility in colorectal cancer. PLoS One.
5:e107142010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shmelkov SV, Butler JM, Hooper AT, et al:
CD133 expression is not restricted to stem cells, and both CD133+
and CD133- metastatic colon cancer cells initiate tumors. J Clin
Invest. 118:2111–2120. 2008.PubMed/NCBI
|
|
30
|
LaBarge MA and Bissell MJ: Is CD133 a
marker of metastatic colon cancer stem cells? J Clin Invest.
118:2021–2024. 2008.PubMed/NCBI
|
|
31
|
Dalerba P, Dylla SJ, Park IK, et al:
Phenotypic characterization of human colorectal cancer stem cells.
Proc Natl Acad Sci USA. 104:10158–10163. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Terunuma H, Deng X, Dewan Z, Fujimoto S
and Yamamoto N: Potential role of NK cells in the induction of
immune responses: implications for NK cell-based immunotherapy for
cancers and viral infections. Int Rev Immunol. 27:93–110. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fernández-Messina L, Reyburn HT and
Valés-Gómez M: Human NKG2D-ligands: cell biology strategies to
ensure immune recognition. Front Immunol. 3:2992012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim JY, Son YO, Park SW, et al: Increase
of NKG2D ligands and sensitivity to NK cell-mediated cytotoxicity
of tumor cells by heat shock and ionizing radiation. Exp Mol Med.
38:474–484. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kim JY, Bae JH, Lee SH, et al: Induction
of NKG2D ligands and subsequent enhancement of NK cell-mediated
lysis of cancer cells by arsenic trioxide. J Immunother.
31:475–486. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bae JH, Kim SJ, Kim MJ, et al:
Susceptibility to natural killer cell-mediated lysis of colon
cancer cells is enhanced by treatment with epidermal growth factor
receptor inhibitors through UL16-binding protein-1 induction.
Cancer Sci. 103:7–16. 2012. View Article : Google Scholar
|
|
37
|
Raulet DH, Gasser S, Gowen BG, et al:
Regulation of ligands for the NKG2D activating receptor. Annu Rev
Immunol. 31:413–441. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
McGilvray RW, Eagle RA, Watson NF, et al:
NKG2D ligand expression in human colorectal cancer reveals
associations with prognosis and evidence for immunoediting. Clin
Cancer Res. 15:6993–7002. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sheard MA, Asgharzadeh S, Liu Y, et al:
Membrane-bound TRAIL supplements natural killer cell cytotoxicity
against neuroblastoma cells. J Immunother. 36:319–329. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tallerico R, Todaro M, Di Franco S, et al:
Human NK cells selective targeting of colon cancer-initiating
cells: a role for natural cytotoxicity receptors and MHC class I
molecules. J Immunol. 190:2381–2390. 2013. View Article : Google Scholar : PubMed/NCBI
|
